The global obesity GLP-1 market size accounted for USD 8.21 billion in 2025 and is predicted to increase from USD 10.12 billion in 2026 to approximately USD 66.57 billion by 2035, expanding at a CAGR of 23.28% from 2026 to 2035
Beyond their primary role in improving glycemic control in patients with T2DM, DPP-4 inhibitors also demonstrate different effects on bone metabolism [107], e.g
(More information) The current recommended dietary allowance (RDA) set by the US National Academy of Medicine is 55 g/day for adolescents and most adults
Make the Right Choice with UrWay Quick Delivery Once approved, most orders are shipped within 24 business hours
If a drug is FDA approved for a particular purpose, that means the Food and Drug Administration (FDA) has deemed the drug to be effective for that purpose, based on reviewing extensive data from clinical trials supporting its use
Results can vary depending on individual factors like metabolism, activity level, and adherence to a healthy lifestyle